SEI Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

SEI Investments’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-39,955	Closed	-$125K	–	2478
2019 Q2	$125K	Sell	39,955 -30,170	-43%	-$97.9K	﹤0.01%	2305
2019 Q1	$261K	Buy	70,125 +32,474	+86%	+$110K	﹤0.01%	2175
2018 Q4	$109K	Buy	+37,651	New	+$103K	﹤0.01%	2180
2018 Q2	–	Sell	-68	Closed	–	–	3985
2018 Q1	$0	Sell	68 -11	-14%	-$30	﹤0.01%	3870
2017 Q4	$0	Sell	79 -23,086	-100%	-$70.9K	﹤0.01%	3668
2017 Q3	$78K	Buy	23,165 +22,761	+5,634%	+$63.3K	﹤0.01%	2164
2017 Q2	$1K	Buy	404 +1	+0.2%	+$2	﹤0.01%	3038
2017 Q1	$1K	Hold	403	–	–	﹤0.01%	2883
2016 Q4	$1K	Hold	403	–	–	﹤0.01%	2888
2016 Q3	$1K	Sell	403 -169	-30%	-$536	﹤0.01%	2809
2016 Q2	$2K	Buy	572 +178	+45%	+$594	﹤0.01%	2517
2016 Q1	$1K	Buy	394 +340	+630%	+$1.06K	﹤0.01%	2487
2015 Q4	$0	Sell	54 -29	-35%	-$121	﹤0.01%	2906
2015 Q3	$0	Hold	83	–	–	﹤0.01%	2709
2015 Q2	$0	Sell	83 -58	-41%	-$389	﹤0.01%	2475
2015 Q1	$0	Sell	141 -31,217	-100%	-$226K	﹤0.01%	2512
2014 Q4	$241K	Buy	+31,358	New	+$248K	﹤0.01%	1352

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SEI Investments's PDLI Position: Q3 2019 in Review

SEI Investments sold out of PDL BioPharma, Inc. (PDLI) in Q3 2019, closing a stake of 39,955 shares — an estimated $125K sold.

SEI Investments first reported a position in PDLI in Q4 2014 and held it in 17 quarters. The position peaked at $261K in Q1 2019. 140 funds tracked by Wall St. Rank hold PDLI as of Q3 2019.

SEI Investments reported no remaining PDL BioPharma, Inc. position as of Q3 2019 after selling out during the quarter.
SEI Investments sold 39,955 PDL BioPharma, Inc. shares in Q3 2019, an estimated $125K.
SEI Investments first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 17 quarters.
SEI Investments's PDL BioPharma, Inc. position peaked at $261K in Q1 2019.
140 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2019.

Based on SEI Investments's 13F filing for Q3 2019, filed 12 Nov 2019.